9.42
price down icon0.32%   -0.03
pre-market  시장 영업 전:  8.64   -0.78   -8.28%
loading
전일 마감가:
$9.45
열려 있는:
$9.46
하루 거래량:
307.52K
Relative Volume:
0.30
시가총액:
$745.16M
수익:
-
순이익/손실:
$-43.16M
주가수익비율:
-17.13
EPS:
-0.55
순현금흐름:
$-29.31M
1주 성능:
+5.25%
1개월 성능:
-1.46%
6개월 성능:
+79.77%
1년 성능:
+177.88%
1일 변동 폭
Value
$9.312
$9.655
1주일 범위
Value
$8.61
$9.80
52주 변동 폭
Value
$3.37
$14.44

Anavex Life Sciences Corporation Stock (AVXL) Company Profile

Name
명칭
Anavex Life Sciences Corporation
Name
전화
844-689-3939
Name
주소
630 5TH AVENUE, NEW YORK
Name
직원
2
Name
트위터
@anavexlifesci
Name
다음 수익 날짜
2024-12-31
Name
최신 SEC 제출 서류
Name
AVXL's Discussions on Twitter

AVXL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AVXL
Anavex Life Sciences Corporation
9.42 745.16M 0 -43.16M -29.31M -0.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-12-06 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2022-06-23 개시 Berenberg Buy
2021-09-23 개시 BTIG Research Buy
2020-12-16 재확인 H.C. Wainwright Buy
2020-09-28 개시 Ladenburg Thalmann Buy
2020-02-27 개시 Cantor Fitzgerald Overweight
2019-06-18 개시 Janney Buy
2018-05-16 재개 Maxim Group Buy
2018-03-08 개시 ROTH Capital Buy
2018-02-13 재확인 Maxim Group Buy
2017-09-29 재개 Noble Financial Buy
2017-02-07 개시 Noble Financial Buy
2016-03-29 개시 FBR Capital Outperform
모두보기

Anavex Life Sciences Corporation 주식(AVXL)의 최신 뉴스

pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 24, 2025

Anavex Life Sciences Corporation’s Market Journey: Closing Strong at 9.31, Up 1.09 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Buying Buzz: Anavex Life Sciences Corporation [AVXL] Director Donhauser Peter D.O. purchases 2,835 shares of the company – Knox Daily - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

AVXL overperforms with a 5.14 increase in share price - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Harvard-Trained Alzheimer's Pioneer With 35,000-Patient Database Strengthens Anavex's Scientific Team - Stock Titan

Apr 23, 2025
pulisher
Apr 21, 2025

Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - Yahoo Finance

Apr 21, 2025
pulisher
Apr 21, 2025

Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer’s Data ... By GuruFocus - Investing.com Canada

Apr 21, 2025
pulisher
Apr 21, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by LPL Financial LLC - Defense World

Apr 21, 2025
pulisher
Apr 21, 2025

Anavex Life Sciences Presents Novel Alzheimer Treatment Research at International Conference in Abu Dhabi - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East - TradingView

Apr 21, 2025
pulisher
Apr 20, 2025

Geode Capital Management LLC Has $20.14 Million Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Holdings Raised by Alliancebernstein L.P. - Defense World

Apr 19, 2025
pulisher
Apr 13, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences LawsuitAVXL - ACCESS Newswire

Apr 13, 2025
pulisher
Apr 13, 2025

Anavex Stock Jumps Pre-Market After Submitting Oral Alzheimer's Drug To European Regulators For Approval: Retail Over The Moon - MSN

Apr 13, 2025
pulisher
Apr 13, 2025

Wellington Management Group LLP Makes New $1.70 Million Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Prudential Financial Inc. Acquires Shares of 10,160 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Vanguard Group Inc. Sells 59,727 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Corebridge Financial Inc. Trims Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Four-Year Data on New Drug for Early AD Positive - streetwisereports.com

Apr 09, 2025
pulisher
Apr 08, 2025

Biotech Company Finds High-Impact Alzheimer's Therapy in Europe - streetwisereports.com

Apr 08, 2025
pulisher
Apr 08, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at D. Boral Capital - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years - Benzinga

Apr 07, 2025
pulisher
Apr 05, 2025

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease - The Manila Times

Apr 05, 2025
pulisher
Apr 05, 2025

Breakthrough: New Alzheimer's Drug Cuts Cognitive Decline Over 4 Years in Clinical Trial - Stock Titan

Apr 05, 2025
pulisher
Apr 05, 2025

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 05, 2025
pulisher
Apr 02, 2025

Class Action Filed Against Anavex Life Sciences Corporation (AVXL)May 13, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class ActionAVXL - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 01, 2025

AVXL’s price-to-free cash flow ratio: What it means for investors - uspostnews.com

Apr 01, 2025
pulisher
Apr 01, 2025

Commonwealth Equity Services LLC Buys 7,285 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Anavex Showcases Breakthrough CNS Therapies: CEO Details Pipeline at Major Healthcare Conference - Stock Titan

Mar 31, 2025
pulisher
Mar 30, 2025

Heartland Advisors Inc. Takes Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat

Mar 30, 2025
pulisher
Mar 28, 2025

19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Acquired by Proficio Capital Partners LLC - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Anavex Life Sciences (NASDAQ:AVXL) Trading Down 3.2%Here's Why - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 25, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Purchased by Intech Investment Management LLC - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

Charles Schwab Investment Management Inc. Purchases 11,239 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 24, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Has $2.37 Million Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 22, 2025
pulisher
Mar 19, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL - Business Wire

Mar 19, 2025
pulisher
Mar 19, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Atria Investments Inc - Defense World

Mar 19, 2025
pulisher
Mar 17, 2025

Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus - TradingView

Mar 17, 2025
pulisher
Mar 13, 2025

Proficio Capital Partners LLC Purchases New Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 13, 2025
pulisher
Mar 09, 2025

Did Anavex Life Sciences Corp. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- AVXL - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 07, 2025

Anavex Life Sciences Corp. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Stake Raised by Rhumbline Advisers - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Private Advisor Group LLC Sells 17,488 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

IMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

Y Intercept Hong Kong Ltd Makes New $243,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 05, 2025

Anavex Life Sciences Corporation (AVXL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):